Dr. Michael Verbora earned an MBA from the Odette School of Business in 2009 and an M.D. from Schulich School of Medicine at Western University in 2013, before entering Family Practice residency at the University of Toronto. To date he has completed over 5,000 cannabinoid therapy consultations, and is a global medical expert in the field of cannabinoid therapy. He serves as Chief Medical Officer of Aleafia Health, a Canadian Producer of medical cannabis and cannabinoid research. Dr. Verbora is also the medical director of Field Trip Health, a mental wellness company focused on psychedelic assisted therapy. He is the primary lead OMA MAPS sponsored study investigating MDMA for eating disorders. Dr. Verbora is committed to helping patients heal through botanical medicines while developing scientific evidence on these therapies.